INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹376 Cr | ₹294 Cr | ₹278 Cr | ₹315 Cr | ₹215 Cr |
What is the latest Total Current Liabilities ratio of INNOVA CAPTAB ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹376 Cr |
| Mar2024 | ₹294 Cr |
| Mar2023 | ₹278 Cr |
| Mar2022 | ₹315 Cr |
| Mar2021 | ₹215 Cr |
How is Total Current Liabilities of INNOVA CAPTAB Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹376 Cr | 28.05 | |
| Mar2024 | ₹294 Cr | 5.92 | |
| Mar2023 | ₹278 Cr | -12.02 | |
| Mar2022 | ₹315 Cr | 46.63 | |
| Mar2021 | ₹215 Cr | - | |
Compare Total Current Liabilities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹3,804.4 Cr | -3.4% | -1.2% | -13.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,407.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,596.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,619.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹98,767.6 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -3.4% |
-1.2% |
-13.9% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses